ATE208761T1 - Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE208761T1 ATE208761T1 AT95108580T AT95108580T ATE208761T1 AT E208761 T1 ATE208761 T1 AT E208761T1 AT 95108580 T AT95108580 T AT 95108580T AT 95108580 T AT95108580 T AT 95108580T AT E208761 T1 ATE208761 T1 AT E208761T1
- Authority
- AT
- Austria
- Prior art keywords
- optionally
- pharmaceutical compositions
- compositions containing
- containing same
- quinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12502294 | 1994-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE208761T1 true ATE208761T1 (de) | 2001-11-15 |
Family
ID=14899924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95108580T ATE208761T1 (de) | 1994-06-07 | 1995-06-05 | Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5641788A (de) |
| EP (1) | EP0686630B1 (de) |
| AT (1) | ATE208761T1 (de) |
| CA (1) | CA2151088A1 (de) |
| DE (1) | DE69523819T2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9801628A2 (hu) * | 1995-04-28 | 1999-01-28 | Takeda Chemical Industries, Ltd. | Artritisz elleni gyógyászati készítmények |
| US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
| WO2006048146A1 (en) * | 2004-11-01 | 2006-05-11 | F. Hoffmann-La Roche Ag | Quinoline as allosteric enhancers of the gaba-b receptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2134169A1 (en) * | 1971-04-23 | 1972-12-08 | Clin Byla Ets | 3-acyl-4-substd - quinoline derivs - analgesics, antiinflammatories, diuretics |
| TW232013B (de) * | 1992-04-24 | 1994-10-11 | Takeda Pharm Industry Co Ltd | |
| NO306992B1 (no) * | 1993-01-28 | 2000-01-24 | Takeda Chemical Industries Ltd | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene |
| EP0634169B1 (de) * | 1993-06-29 | 2000-01-05 | Takeda Chemical Industries, Ltd. | Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose |
-
1995
- 1995-06-02 US US08/460,776 patent/US5641788A/en not_active Expired - Fee Related
- 1995-06-05 EP EP95108580A patent/EP0686630B1/de not_active Expired - Lifetime
- 1995-06-05 DE DE69523819T patent/DE69523819T2/de not_active Expired - Fee Related
- 1995-06-05 AT AT95108580T patent/ATE208761T1/de not_active IP Right Cessation
- 1995-06-06 CA CA002151088A patent/CA2151088A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0686630A1 (de) | 1995-12-13 |
| US5641788A (en) | 1997-06-24 |
| DE69523819T2 (de) | 2002-08-22 |
| CA2151088A1 (en) | 1995-12-08 |
| EP0686630B1 (de) | 2001-11-14 |
| DE69523819D1 (de) | 2001-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE247654T1 (de) | Neue heterozyklische verbindungen | |
| DE69604714T2 (de) | Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
| DK0528337T3 (da) | Thiazolylbenzofuranderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater, der indeholder disse forbin | |
| NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
| FI850140A0 (fi) | Kemiska foereningar. | |
| IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
| NZ234249A (en) | Optionally heterocyclically-substituted pyridine derivatives and pharmaceutical compositions | |
| ATE227293T1 (de) | 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one | |
| EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
| DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
| DE69215694D1 (de) | Benzamid-derivate | |
| PT992509E (pt) | Novos derivados macrolidos | |
| DE69821815D1 (de) | Thiocolchicin-Derivate mit entzündungshemmender und muskelrelaxierender Wirkung | |
| FI920435A (fi) | N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel. | |
| ATE208761T1 (de) | Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DK0570850T3 (da) | Benzo(b)thiophen-3-yl-piperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| DE69327077T2 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
| DK0823254T3 (da) | Hidtil ukendt anvendelse af pyrazolopyridinforbindelser | |
| DE3772850D1 (de) | Thiadiazinon-derivate. | |
| IT1210914B (it) | Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |